Cargando…

Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis

BACKGROUND: We studied two cases of rare fibrous bone tumors, namely desmoplastic fibroma (DF) and low-grade central osteosarcoma (LGCOS) resembling desmoplastic fibroma (DF-like LGCOS). As the clinical presentation, imaging features and histopathology of DF and DF-like LGOS show much overlap, the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Wangzhao, van den Berg, Eva, Kwee, Thomas C., Jutte, Paul C., Cleton-Jansen, Anne-Marie, Bovée, Judith V. M. G., Suurmeijer, Albert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106748/
https://www.ncbi.nlm.nih.gov/pubmed/30159138
http://dx.doi.org/10.1186/s13569-018-0104-z
_version_ 1783349839783788544
author Song, Wangzhao
van den Berg, Eva
Kwee, Thomas C.
Jutte, Paul C.
Cleton-Jansen, Anne-Marie
Bovée, Judith V. M. G.
Suurmeijer, Albert J.
author_facet Song, Wangzhao
van den Berg, Eva
Kwee, Thomas C.
Jutte, Paul C.
Cleton-Jansen, Anne-Marie
Bovée, Judith V. M. G.
Suurmeijer, Albert J.
author_sort Song, Wangzhao
collection PubMed
description BACKGROUND: We studied two cases of rare fibrous bone tumors, namely desmoplastic fibroma (DF) and low-grade central osteosarcoma (LGCOS) resembling desmoplastic fibroma (DF-like LGCOS). As the clinical presentation, imaging features and histopathology of DF and DF-like LGOS show much overlap, the objective of this study was to investigate the value of cytogenetic analysis, molecular pathology and immunohistochemistry in discrimination of these two mimickers. CASE PRESENTATION: A mutation in CTNNB (S45F) and nuclear beta-catenin immunostaining were observed in DF. DF-LGCOS had amplification of CDK4 and showed strong nuclear expression of CDK4 by IHC. Moreover, the karyotype of DF-LGCOS showed an interstitial heterozygous deletion of the long arm of chromosome 13 (q12q32), associated with loss of the RB1 tumor suppressor gene. CONCLUSIONS: Karyotyping and molecular genetic analysis may contribute to a conclusive diagnosis.
format Online
Article
Text
id pubmed-6106748
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61067482018-08-29 Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis Song, Wangzhao van den Berg, Eva Kwee, Thomas C. Jutte, Paul C. Cleton-Jansen, Anne-Marie Bovée, Judith V. M. G. Suurmeijer, Albert J. Clin Sarcoma Res Case Report BACKGROUND: We studied two cases of rare fibrous bone tumors, namely desmoplastic fibroma (DF) and low-grade central osteosarcoma (LGCOS) resembling desmoplastic fibroma (DF-like LGCOS). As the clinical presentation, imaging features and histopathology of DF and DF-like LGOS show much overlap, the objective of this study was to investigate the value of cytogenetic analysis, molecular pathology and immunohistochemistry in discrimination of these two mimickers. CASE PRESENTATION: A mutation in CTNNB (S45F) and nuclear beta-catenin immunostaining were observed in DF. DF-LGCOS had amplification of CDK4 and showed strong nuclear expression of CDK4 by IHC. Moreover, the karyotype of DF-LGCOS showed an interstitial heterozygous deletion of the long arm of chromosome 13 (q12q32), associated with loss of the RB1 tumor suppressor gene. CONCLUSIONS: Karyotyping and molecular genetic analysis may contribute to a conclusive diagnosis. BioMed Central 2018-08-23 /pmc/articles/PMC6106748/ /pubmed/30159138 http://dx.doi.org/10.1186/s13569-018-0104-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Song, Wangzhao
van den Berg, Eva
Kwee, Thomas C.
Jutte, Paul C.
Cleton-Jansen, Anne-Marie
Bovée, Judith V. M. G.
Suurmeijer, Albert J.
Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis
title Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis
title_full Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis
title_fullStr Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis
title_full_unstemmed Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis
title_short Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis
title_sort low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106748/
https://www.ncbi.nlm.nih.gov/pubmed/30159138
http://dx.doi.org/10.1186/s13569-018-0104-z
work_keys_str_mv AT songwangzhao lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis
AT vandenbergeva lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis
AT kweethomasc lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis
AT juttepaulc lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis
AT cletonjansenannemarie lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis
AT boveejudithvmg lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis
AT suurmeijeralbertj lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis